HopeStage
Back to all studies
CompletedNCT03512418

PrEPSteps: A Digital Pill and Smartphone Support for PrEP

About this titleRead the official source — NCT03512418
Medication studyAges 18+United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
BoylstonSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: June 20, 2019
Recruitment status
Completed
Enrollment listed in the registry
30
Sponsor
Brigham and Women's Hospital
Sponsor type
Hospital / academic medical center
Study type
Behavioral
Intervention type
Behavioural, Device, Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT03512418
Official title
Show the full official title

Development of Ingestible Biosensors to Enhance PrEP Adherence in Substance Users (PrEPSteps)

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Boylston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Brigham and Women's Hospital, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including Truvada.

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies